Generic pain, margin loss: Drug companies may find it hard to adjust with Trump's tariff plans
US President Trump's 25% tariff plan on pharmaceuticals jeopardizes Indian pharma exports, making generics pricier and ...
Reconsider price display order: Pharmacists' lobby to NPPA
As reported by ET last week, the drug pricing regulator had asked all retailers and dealers to display the current price list ...